Mode
Text Size
Log in / Sign up
N/A Completed N=26 Treatment

Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)

Source: ClinicalTrials.gov NCT01659125 ↗
Enrolled (actual)
26
Serious AEs
4.2%
Results posted
Jan 2016
Primary outcomePrimary: Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) — 24.67; 18.29; 18.46 units on a scale

Summary

The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
24.67; 18.29; 18.46
PRIMARY
Responder Status
5; 5

Eligibility Criteria

Inclusion Criteria

  • Principal or co-principal diagnosis of OCD
  • Clinical global impression score greater than or equal to 4
  • Y-BOCS score great than or equal to 8
  • Fluency in English
  • Capacity to understand the nature of the study and willingness to sign informed consent form

Exclusion Criteria

  • Active manic episode, psychosis, pervasive developmental disorder, mental retardation
  • Concurrent OCD psychotherapy
  • Current threat of harm to self or others
  • Previous adequate trial of therapist-administered or self-administered exposure and response prevention for OCD
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01659125). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search